MENU
APR 02, 2012 8:00 AM PDT

D-dimer in the Management of Venous Thromboembolism

Sponsored by: Diagnostica Stago, Inc.
Speaker
  • Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
    Biography
      Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General's task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master's degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.

    Abstract

    Venous thromboembolism (VTE) is a serious prothrombotic disease state caused by acquired or inherited factors and is responsible for a high rate of morbidity and mortality.  Deep venous thrombosis (DVT) and pulmonary embolism (PE) refer to VTE located in the deep veins or lungs, respectively.  Diagnostic strategies for identification of VTE, DVT, and PE include imaging as well as laboratory testing methodologies such as the D-dimer assay.  The purpose of this educational activity is to review clinical decision rules, case studies, and the role of the D-dimer assay in the diagnostic management of VTE.

    • Recognize venous thromboembolism: deep-vein thrombosis and pulmonary embolism and its consequences.
    • Discuss the use of D-dimer in the exclusion of patients with clinically suspected first-episode or recurrent deep-vein thrombosis.
    • Discuss the utility of D-dimer in the determination of length of anticoagulation after first-episode deep-vein thrombosis.

    Show Resources
    You May Also Like
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAR 11, 2020 6:00 AM PDT
    C.E. CREDITS
    MAR 11, 2020 6:00 AM PDT
    The locomotion of humans and other animals requires a seamless flow of information from sensory modalities all the way to the motor periphery. As such, locomotion is an excellent system for...
    APR 30, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 30, 2020 8:00 AM PDT
    DATE:April 30, 2020 TIME: 8AM PT, 11AM ET, 4PM BST, 5PM CEST Cytokinesis is the physical separation of two cells that occurs after the completion of mitosis. The mechanism underlying it is v...
    AUG 26, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    AUG 26, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
    Loading Comments...
    Show Resources
    Attendees
    • See more